2015
DOI: 10.1016/bs.apar.2015.01.002
|View full text |Cite
|
Sign up to set email alerts
|

Economic and Financial Evaluation of Neglected Tropical Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
15
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
5
3
1

Relationship

2
7

Authors

Journals

citations
Cited by 24 publications
(15 citation statements)
references
References 98 publications
0
15
0
Order By: Relevance
“…Other diseases occurring in the same geographic area cause anemia and cognitive impairment (e.g., malaria, schistosomiasis, and meningitis), which may make it difficult to attribute the true underlying cause and infected individuals may not seek care or be appropriately diagnosed. [ 40 ] Data used in our model came from a variety of sources and studies of variable quality; therefore our results may change as more data becomes available. For example, hookworm prevalence data is limited; it tends to be extrapolated from localized cross-sectional surveys, many of which are done in high prevalence areas with differing data collection methods.…”
Section: Discussionmentioning
confidence: 99%
“…Other diseases occurring in the same geographic area cause anemia and cognitive impairment (e.g., malaria, schistosomiasis, and meningitis), which may make it difficult to attribute the true underlying cause and infected individuals may not seek care or be appropriately diagnosed. [ 40 ] Data used in our model came from a variety of sources and studies of variable quality; therefore our results may change as more data becomes available. For example, hookworm prevalence data is limited; it tends to be extrapolated from localized cross-sectional surveys, many of which are done in high prevalence areas with differing data collection methods.…”
Section: Discussionmentioning
confidence: 99%
“…Ivermectin is currently donated for onchocerciasis and lymphatic filariasis control ( 25 Years: The MECTIZANⓇ Donation Program ), but not directly for STH. Consequently, the actual financial cost of ivermectin and/or its potential economic value if it were to be donated for STH needs to be estimated to allow future cost-effectiveness analysis (an important gap for NTDs ( Turner et al, 2014b , Turner et al, 2015a , Lee et al, 2015 )).…”
Section: Discussionmentioning
confidence: 99%
“…There is also evidence to suggest that these benefits of MDA can subsequently reduce morbidity[44]. Additionally, some studies have shown increases in school attendance with anthelminthic treatment[45, 46] and MDA had been found to be a cost-effective intervention for STH infections[14, 47]. …”
Section: Discussionmentioning
confidence: 99%